Each year, more than 300,000 people around the world are diagnosed with oral cancer. Now, with the advancement of technology, oral health care providers have a variety of screening options at their fingertips. Luckily, these advancements help providers identify and evaluate abnormal lesions within the mouth. Some lesions may be too challenging to visually detect in a standard examination. ViziLite is a device that aids the naked eye in recognizing cancerous cells.
The Importance of Early Screening
An oral cancer screening system, ViziLite detects soft tissue abnormalities throughout mouth. The device emits blue LED lighting that detects precancerous lesions. Therefore, the oral technology is most effective in early detection of oral cancer in patients who may not show any symptoms of the disease.
Tissue biopsy and histopathological examination remain the leading diagnostic tools. However, ViziLite has become a valid option in early detection and screening. Now, dentists can contribute to the survival rate of patients by incorporating an oral cancer screening light exam into traditional head and neck oral exams.
This screening gives providers the ability to identify cancer early. This is especially important for patients who are more susceptible to oral cancer and those who may not show symptoms. Coupled with a standard visual exam, the ViziLite device can provide a comprehensive, painless oral screening procedure for patients at high risk for oral cancer.
What Next?
Should you have questions about oral cancer and standard screening, give us a call to schedule a consultation. Remember that early detection of cancer substantially increases the likelihood of recovery. In fact, the five-year survival rates for oral cancer victims increases dramatically from 57% to 83% when oral abnormalities are discovered early.